Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Competition in Biofilms between Cystic Fibrosis Isolates of Pseudomonas aeruginosa Is Shaped by R-Pyocins.

Oluyombo O, Penfold CN, Diggle SP.

MBio. 2019 Jan 29;10(1). pii: e01828-18. doi: 10.1128/mBio.01828-18.

2.

Colicin import into E. coli cells: a model system for insights into the import mechanisms of bacteriocins.

Kim YC, Tarr AW, Penfold CN.

Biochim Biophys Acta. 2014 Aug;1843(8):1717-31. doi: 10.1016/j.bbamcr.2014.04.010. Epub 2014 Apr 16. Review.

3.

Detection of induced synthesis of colicin E9 using ColE9p::gfpmut2 based reporter system.

Bano S, Vankemmelbeke M, Penfold CN, James R.

World J Microbiol Biotechnol. 2014 Jul;30(7):2091-9. doi: 10.1007/s11274-014-1635-y. Epub 2014 Mar 21.

PMID:
24652519
4.

Immunity protein release from a cell-bound nuclease colicin complex requires global conformational rearrangement.

Vankemmelbeke M, Housden NG, James R, Kleanthous C, Penfold CN.

Microbiologyopen. 2013 Oct;2(5):853-61. doi: 10.1002/mbo3.122. Epub 2013 Aug 28.

5.

Pattern of induction of colicin E9 synthesis by sub MIC of Norfloxacin antibiotic.

Bano S, Vankemmelbeke M, Penfold CN, James R.

Microbiol Res. 2013 Dec 14;168(10):661-6. doi: 10.1016/j.micres.2013.04.005. Epub 2013 May 10.

6.

Membrane activities of colicin nuclease domains: analogies with antimicrobial peptides.

Vankemmelbeke M, James R, Penfold CN.

Biochem Soc Trans. 2012 Dec 1;40(6):1517-21. doi: 10.1042/BST20120233. Review.

PMID:
23176509
7.

Colicin A binds to a novel binding site of TolA in the Escherichia coli periplasm.

Penfold CN, Li C, Zhang Y, Vankemmelbeke M, James R.

Biochem Soc Trans. 2012 Dec 1;40(6):1469-74. doi: 10.1042/BST20120239. Review.

PMID:
23176500
8.

How bugs kill bugs: progress and challenges in bacteriocin research.

Penfold CN, Walker D, Kleanthous C.

Biochem Soc Trans. 2012 Dec 1;40(6):1433-7. doi: 10.1042/BST20120253.

PMID:
23176494
9.

Interaction of nuclease colicins with membranes: insertion depth correlates with bilayer perturbation.

Vankemmelbeke M, O Shea P, James R, Penfold CN.

PLoS One. 2012;7(9):e46656. doi: 10.1371/journal.pone.0046656. Epub 2012 Sep 28.

10.

Structural evidence that colicin A protein binds to a novel binding site of TolA protein in Escherichia coli periplasm.

Li C, Zhang Y, Vankemmelbeke M, Hecht O, Aleanizy FS, Macdonald C, Moore GR, James R, Penfold CN.

J Biol Chem. 2012 Jun 1;287(23):19048-57. doi: 10.1074/jbc.M112.342246. Epub 2012 Apr 9.

11.

Characterisation of the interaction of colicin A with its co-receptor TolA.

Hecht O, Zhang Y, Li C, Penfold CN, James R, Moore GR.

FEBS Lett. 2010 Jun 3;584(11):2249-52. doi: 10.1016/j.febslet.2010.04.061. Epub 2010 Apr 29.

12.

The crystal structure of the TolB box of colicin A in complex with TolB reveals important differences in the recruitment of the common TolB translocation portal used by group A colicins.

Zhang Y, Li C, Vankemmelbeke MN, Bardelang P, Paoli M, Penfold CN, James R.

Mol Microbiol. 2010 Feb;75(3):623-36. doi: 10.1111/j.1365-2958.2009.06808.x. Epub 2009 Jul 21.

13.

Energy-dependent immunity protein release during tol-dependent nuclease colicin translocation.

Vankemmelbeke M, Zhang Y, Moore GR, Kleanthous C, Penfold CN, James R.

J Biol Chem. 2009 Jul 10;284(28):18932-41. doi: 10.1074/jbc.M806149200. Epub 2009 May 19.

14.

Design of a polypeptide FRET substrate that facilitates study of the antimicrobial protease lysostaphin.

Bardelang P, Vankemmelbeke M, Zhang Y, Jarvis H, Antoniadou E, Rochette S, Thomas NR, Penfold CN, James R.

Biochem J. 2009 Mar 15;418(3):615-24. doi: 10.1042/BJ20081765.

PMID:
19032148
15.

Investigating early events in receptor binding and translocation of colicin E9 using synchronized cell killing and proteolytic cleavage.

Zhang Y, Vankemmelbeke MN, Holland LE, Walker DC, James R, Penfold CN.

J Bacteriol. 2008 Jun;190(12):4342-50. doi: 10.1128/JB.00047-08. Epub 2008 Apr 11.

16.

Repair of the deep circumflex iliac artery free flap donor site with Protack (titanium spiral tacks) and Prolene (polypropylene) mesh.

Iqbal M, Lloyd CJ, Paley MD, Penfold CN.

Br J Oral Maxillofac Surg. 2007 Oct;45(7):596-7. Epub 2007 Mar 8. No abstract available.

PMID:
17349725
17.

Interactions of TolB with the translocation domain of colicin E9 require an extended TolB box.

Hands SL, Holland LE, Vankemmelbeke M, Fraser L, Macdonald CJ, Moore GR, James R, Penfold CN.

J Bacteriol. 2005 Oct;187(19):6733-41.

18.

Clusters in an intrinsically disordered protein create a protein-binding site: the TolB-binding region of colicin E9.

Tozawa K, Macdonald CJ, Penfold CN, James R, Kleanthous C, Clayden NJ, Moore GR.

Biochemistry. 2005 Aug 30;44(34):11496-507.

PMID:
16114886
19.

Rapid detection of colicin E9-induced DNA damage using Escherichia coli cells carrying SOS promoter-lux fusions.

Vankemmelbeke M, Healy B, Moore GR, Kleanthous C, Penfold CN, James R.

J Bacteriol. 2005 Jul;187(14):4900-7. Erratum in: J Bacteriol. 2005 Sep;187(18):6601.

20.

Total mandibular reconstruction for massive osteolysis of the mandible (Gorham-Stout syndrome).

Paley MD, Lloyd CJ, Penfold CN.

Br J Oral Maxillofac Surg. 2005 Apr;43(2):166-8.

PMID:
15749219
21.

Characterisation of a mobile protein-binding epitope in the translocation domain of colicin E9.

Macdonald CJ, Tozawa K, Collins ES, Penfold CN, James R, Kleanthous C, Clayden NJ, Moore GR.

J Biomol NMR. 2004 Sep;30(1):81-96.

PMID:
15452437
22.

Flexibility in the receptor-binding domain of the enzymatic colicin E9 is required for toxicity against Escherichia coli cells.

Penfold CN, Healy B, Housden NG, Boetzel R, Vankemmelbeke M, Moore GR, Kleanthous C, James R.

J Bacteriol. 2004 Jul;186(14):4520-7.

23.

OmpF enhances the ability of BtuB to protect susceptible Escherichia coli cells from colicin E9 cytotoxicity.

Law CJ, Penfold CN, Walker DC, Moore GR, James R, Kleanthous C.

FEBS Lett. 2003 Jun 19;545(2-3):127-32.

25.

Microvascular free tissue transfer in the management of squamous cell carcinoma of the tongue during pregnancy.

Lloyd CJ, Paley MD, Penfold CN, Varadarajan V, Tehan B, Gollins SW.

Br J Oral Maxillofac Surg. 2003 Apr;41(2):109-11.

PMID:
12694703
26.

Killing of E coli cells by E group nuclease colicins.

James R, Penfold CN, Moore GR, Kleanthous C.

Biochimie. 2002 May-Jun;84(5-6):381-9. Review.

PMID:
12423781
27.
28.

Structural dynamics of the membrane translocation domain of colicin E9 and its interaction with TolB.

Collins ES, Whittaker SB, Tozawa K, MacDonald C, Boetzel R, Penfold CN, Reilly A, Clayden NJ, Osborne MJ, Hemmings AM, Kleanthous C, James R, Moore GR.

J Mol Biol. 2002 May 3;318(3):787-804.

PMID:
12054823
29.

Chronic eosinophilic pneumonia associated with T-cell lymphoma.

Thiruchelvam JK, Penfold CN, Akhtar S.

Int J Oral Maxillofac Surg. 2002 Feb;31(1):112-4.

PMID:
11936394
30.

A 76-residue polypeptide of colicin E9 confers receptor specificity and inhibits the growth of vitamin B12-dependent Escherichia coli 113/3 cells.

Penfold CN, Garinot-Schneider C, Hemmings AM, Moore GR, Kleanthous C, James R.

Mol Microbiol. 2000 Nov;38(3):639-49.

32.

Management of velopharyngeal dysfunction.

Penfold CN.

Br J Oral Maxillofac Surg. 1997 Dec;35(6):454. No abstract available.

PMID:
9486456
33.

Identification of residues in the putative TolA box which are essential for the toxicity of the endonuclease toxin colicin E9.

Garinot-Schneider C, Penfold CN, Moore GR, Kleanthous C, James R.

Microbiology. 1997 Sep;143 ( Pt 9):2931-8.

PMID:
9308177
34.

Facial lymphangioma.

Adeniran IO, Penfold CN.

Br J Oral Maxillofac Surg. 1997 Feb;35(1):74. No abstract available.

PMID:
9043015
35.
36.

A review of 23 patients with tuberculosis of the head and neck.

Penfold CN, Revington PJ.

Br J Oral Maxillofac Surg. 1996 Dec;34(6):508-10.

PMID:
8971444
37.

Minimum standards for the management of cleft lip and palate: efforts to close the audit loop.

Penfold CN.

Ann R Coll Surg Engl. 1996 Sep;78(5):477-8. No abstract available.

38.

Combined radial forearm and pharyngeal flap for soft palate reconstruction.

Penfold CN, Brown AE, Lavery KM, Venn PJ.

Br J Oral Maxillofac Surg. 1996 Aug;34(4):322-4.

PMID:
8866069
39.

Isolation, characterisation and expression of the bacterioferritin gene of Rhodobacter capsulatus.

Penfold CN, Ringeling PL, Davy SL, Moore GR, McEwan AG, Spiro S.

FEMS Microbiol Lett. 1996 Jun 1;139(2-3):143-8.

PMID:
8674981
40.

The role of angiogenesis in the spread of oral squamous cell carcinoma.

Penfold CN, Partridge M, Rojas R, Langdon JD.

Br J Oral Maxillofac Surg. 1996 Feb;34(1):37-41.

PMID:
8645680
42.

Pain-free oral surgery.

Penfold CN.

Dent Update. 1993 Dec;20(10):421-6. Review.

PMID:
8056091
43.

Giant cell lesions complicating Paget's disease of bone and their response to calcitonin therapy.

Penfold CN, Evans BT.

Br J Oral Maxillofac Surg. 1993 Aug;31(4):267. No abstract available.

PMID:
8399049
44.

Giant cell lesions complicating fibro-osseous conditions of the jaws.

Penfold CN, McCullagh P, Eveson JW, Ramsay A.

Int J Oral Maxillofac Surg. 1993 Jun;22(3):158-62.

PMID:
8340626
45.

Combined latissimus dorsi-serratus anterior/rib composite free flap in mandibular reconstruction.

Penfold CN, Davies HT, Cole RP, Evans BT, Hobby JA.

Int J Oral Maxillofac Surg. 1992 Apr;21(2):92-6.

PMID:
1602168
46.

The management of orbital roof fractures.

Penfold CN, Lang D, Evans BT.

Br J Oral Maxillofac Surg. 1992 Apr;30(2):97-103.

PMID:
1567811
47.

Neonatal giant lymph node hyperplasia (Castleman's disease) presenting in the head and neck.

Penfold CN, Cottrell BJ, Talbot R.

Br J Oral Maxillofac Surg. 1991 Apr;29(2):110-1. Review.

PMID:
2049350
48.

Mikulicz syndrome.

Penfold CN.

J Oral Maxillofac Surg. 1985 Nov;43(11):900-5. No abstract available.

PMID:
3903084

Supplemental Content

Loading ...
Support Center